Oral administration of one dose of cholera toxin induces a systemic immune response prior to a mucosal immune response by a direct presentation in the spleen

Immunology Letters

Volumn 60, Issue 2-3, 1998, Pages 149-156

  Benedetti, Ruben ^a   Lev, Paola ^a   Massouh, Ernesto ^a   Fló, Juan ^a  

^a Fac Cie E   (Argentina)

Author keywords

Antigen presenting cells; Cholera toxin; Oral immunization; Primary immune response

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; CHOLERA; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOCYTE CULTURE; MESENTERY LYMPH NODE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEYER PATCH; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGEN-PRESENTING CELLS; ANTITOXINS; CHOLERA TOXIN; IMMUNITY, MUCOSAL; KINETICS; RATS; RATS, WISTAR; SPLEEN; TIME FACTORS; VIBRIO CHOLERAE;

EID: 0032007490     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(97)00152-1     Document Type: Article

References (26)

1. Ermak T.H., Owen R.L. Anat. Res. 215:1986;144.
2. McGhee J.R., Mestecky J., Elson C.O., Kiyono H. J. Clin. Immunol. 9:1989;175.
3. Nedrud J.G., Lamm M.E. Adjuvants and the mucosal immune system. 1991;54-67 CRC Press, Boca Raton, FL.
4. Pierce N.F., Gowans J.L. J. Exp. Med. 142:1975;1550.
5. Pierce N. J. Exp. Med. 148:1978;195.
6. Pierce N.F., Cray W.C. Jr. J. Immunol. 128:1982;1311.
7. Lycke N., Lindholm L., Holmgren J. Int. Arch. Allergy Appl. Immunol. 72:1983;119.
8. Lemaitre-Coelho I., Jackson G.D.F., Vaerman J.P. Scand. J. Immunol. 8:1978;459.
9. Holmgren J., Czerkinsky C., Lycke N., Svennerholm A.M. Am. J. Trop. Med. Hyg. 50:1994;42.
10. Fujita K., Finkelstein R. J. Infect. Dis. 125:1972;647.
11. Elson C.O., Ealding W. J. Immunol. 132:1984;2736.
12. Lycke N., Holmgren J. Immunology. 59:1986;301.
13. Elson C.O., Ealding W. J. Immunol. 133:1984;2892.
14. Holmgren J., Lycke N., Czerkinsky C. Vaccine. 11:1993;1179.
15. Lycke N., Karlsson U., Sjolander A., Magnusson K.E. Scand. J. Immunol. 33:1991;691.
16. Flo J., Roux M.E., Massouh E. Infect. Immun. 62:1994;4948.
17. Benedetti R., Massouh E., Flo J. Immunol. Lett. 48:1995;109.
18. N. Lycke, A.M. Svennerholm, The presentation of immunogens at the gut and other mucosal surfaces, in: G. Woodrow, M. Levine (Eds.), New Generation Vaccines, Marcel Dekker, New York, 1990, pp. 217-227.
19. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. Vaccine. 10:1992;75.
20. Cebra J.J., Gearhart P.J., Kamat R., Robertson S.M., Tseng J. Cold Spring Harbor Symp. Quant. Biol. 41:1976;215.
21. Husband A.J., Gowans J.L. J. Exp. Med. 148:1978;1146.
22. Lycke N., Holmgren J. Scand. J. Immunol. 23:1986;611.
23. McWillams M., Phillips-Quagliata J.M., Lamm M.E. J. Exp. Med. 145:1977;866.
24. Lycke N., Holmgren J. Scand. J. Immunol. 25:1987;407.
25. Hornquist C.E., Ekman L., Grdic K.D., Schon K., Lycke N.Y. J. Immunol. 155:1995;2877.
26. Vajdy M., Koscovilbois M.H., Kopf M., Kohler G., Lycke N. J. Exp. Med. 181:1995;41.